SAM
HRMY icon

SEB Asset Management’s Harmony Biosciences HRMY Stock Holding History

SEB Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Sell
18,014
-22,518
-56% -$710K ﹤0.01% 637
2026
Q1 		$1.14M Buy
+40,532
New +$1.33M ﹤0.01% 615

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SEB Asset Management's HRMY Position: Q2 2026 in Review

SEB Asset Management reduced its Harmony Biosciences (HRMY) stake by 56% in Q2 2026, selling an estimated $710K and leaving 18,014 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

SEB Asset Management first reported a position in HRMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.14M in Q1 2026. 301 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • SEB Asset Management held 18,014 shares of Harmony Biosciences worth $656K as of Q2 2026.
  • SEB Asset Management sold 22,518 Harmony Biosciences shares in Q2 2026, an estimated $710K.
  • Harmony Biosciences made up ﹤0.01% of SEB Asset Management's portfolio in Q2 2026, its #637 holding.
  • SEB Asset Management first reported a position in Harmony Biosciences in Q1 2026 and has held it in 2 quarters since.
  • SEB Asset Management's Harmony Biosciences position peaked at $1.14M in Q1 2026.
  • 301 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.